Introducing Brenzavvy, the generic for Bexagliflozin, Anti‑Diabetes Tablets – a novel SGLT2 inhibitor designed to reduce blood glucose by promoting urinary glucose excretion. It lowers hyperglycemia and supports weight management while enhancing metabolic control. Experience improved glycemic balance and cardiovascular outcomes with this innovative treatment for optimal diabetes management.